Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Cancer|September 1, 1990
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological GroupP H Smith, A Bono, F Calais da Silva, et al.
The Journal of Urology|August 1, 1997
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection aloneK Kurth, U Tunn, R Ay, et al.
The Journal of Urology|May 1, 1995
The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter studyA Tubaro, S S Carter, J de la Rosette, et al.
The Journal of Urology|August 1, 1984
Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection aloneK H Kurth, F H Schröder, U Tunn, et al.
Prostate Cancer and Prostatic Diseases|November 15, 2006
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-upM Wirth, C Tyrrell, K Delaere, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2005
Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programmeM Wirth, C Tyrrell, K Delaere, et al.
Urology|April 1, 1997
Evaluation and follow-up of patients with N1-3 M0 or NXM1 prostate cancer in phase III trialsR Hall, P O Hedlund, R Ackermann, et al.
Pageof 10